Waldron Private Wealth LLC Has $590,000 Stock Position in MetLife, Inc. (NYSE:MET)

Waldron Private Wealth LLC grew its position in MetLife, Inc. (NYSE:MET) by 4.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,150 shares of the financial services provider’s stock after buying an additional 332 shares during the quarter. Waldron Private Wealth LLC’s holdings in MetLife were worth $590,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in MET. Vanguard Group Inc. lifted its position in shares of MetLife by 3.4% in the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock worth $4,418,612,000 after purchasing an additional 1,974,268 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of MetLife by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after purchasing an additional 988,666 shares in the last quarter. Legal & General Group Plc lifted its position in shares of MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock worth $371,993,000 after purchasing an additional 269,246 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of MetLife by 3.2% in the second quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider’s stock worth $226,358,000 after purchasing an additional 100,782 shares in the last quarter. Finally, Nordea Investment Management AB lifted its position in shares of MetLife by 4.1% in the first quarter. Nordea Investment Management AB now owns 2,772,751 shares of the financial services provider’s stock worth $205,544,000 after purchasing an additional 108,739 shares in the last quarter. 89.81% of the stock is currently owned by institutional investors and hedge funds.

MetLife Trading Down 0.1 %

Shares of MetLife stock opened at $84.77 on Wednesday. The company’s fifty day simple moving average is $79.11 and its 200-day simple moving average is $74.29. The company has a market cap of $60.28 billion, a price-to-earnings ratio of 29.13, a PEG ratio of 0.69 and a beta of 1.04. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56. MetLife, Inc. has a 1 year low of $57.91 and a 1 year high of $86.94.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.15. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The business had revenue of $17.82 billion for the quarter, compared to the consensus estimate of $18.57 billion. During the same quarter last year, the company posted $1.94 earnings per share. MetLife’s quarterly revenue was up 7.2% on a year-over-year basis. As a group, sell-side analysts expect that MetLife, Inc. will post 8.61 EPS for the current year.

MetLife Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.57%. MetLife’s dividend payout ratio is currently 74.91%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MET. Wells Fargo & Company increased their price target on shares of MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Barclays initiated coverage on shares of MetLife in a research report on Wednesday, September 4th. They set an “overweight” rating and a $91.00 price objective on the stock. JPMorgan Chase & Co. raised their price objective on shares of MetLife from $81.00 to $86.00 and gave the company an “overweight” rating in a research report on Tuesday, July 2nd. Morgan Stanley cut their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Finally, StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $88.46.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.